Earnings dates and session timing shown here are aggregated from third-party sources, are frequently estimated, and are subject to change or confirmation by the reporting company. Nothing on this site is financial advice.
Scienture Holdings, Inc. (SCNX) is a pioneering biotechnology firm focused on transforming the treatment landscape for neurological disorders through its advanced drug development pipeline and a seasoned research team. The company is dedicated to addressing significant unmet medical needs, highlighting its potential to enhance patient outcomes while skillfully navigating regulatory complexities. With a strong emphasis on scientific integrity and strategic collaborations, Scienture is well-positioned to leverage growth opportunities in the burgeoning global healthcare market, particularly as the demand for effective neurological therapies continues to rise.
Quotes and fundamental data are delayed and provided for informational purposes only — nothing on this page is financial advice. Figures are as reported by the company and its data providers and may be revised. Estimates reflect analyst consensus at the time of each report.
$0.36
| Quarter | EPS | Revenue | Price move | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Est | Adj | Result | GAAP | Est | Actual | Surprise | 1D Pre | On-Day | 1D Post | |
Q ended Jun 30, 2026 Reported Aug 13, 2026 | $-0.09 | $-0.07 | Beat +22.2% | $-0.07 | $0 | $343.6K | — | 1D Pre+10.0% | On-Day+3.3% | 1D Post-1.3% |
Q ended Mar 31, 2026 Reported May 11, 2026 | $-0.22 | $-0.08 | Beat +63.6% | $-0.08 | $0 | $56.3K | — | 1D Pre-5.9% | On-Day+0.9% | 1D Post-1.5% |
Q ended Dec 31, 2025 Reported Mar 24, 2026 | $-0.28 | $-0.13 | ||||||||
Dashed outlines show the analyst consensus estimate for periods where one was published. Hover or tap a bar for exact figures. Values as reported; not adjusted for splits after the report date.
| — |
| $0 |
| -$168.7K |
| — |
| 1D Pre+1.0% |
| On-Day-5.1% |
| 1D Post-0.3% |
Q ended Sep 30, 2025 Reported Nov 12, 2025 | $0.00 | $-0.19 | Miss | — | — | $590.0K | — | 1D Pre+7.5% | On-Day-4.0% | 1D Post-5.5% |